SLGL (SLGL) Stock Price & Analysis
SLGL (SLGL) fell 0.83% to USD 69.52 as of September 8, 2026 at 10:15 UTC, according to Nexqual real-time market data.
SLGL last closed at USD 69.52; the session ranged USD 68.39–70.8 on volume of 29,627 shares. Market capitalization is —, with a 52-week range of USD 23.13–97.97 (NCM). Source: Nexqual, September 8, 2026 at 10:15 UTC.
Key Statistics (as of September 8, 2026 at 10:15 UTC)
| Price | USD 69.52 |
|---|---|
| Change | ▼ 0.83% (down) |
| Previous Close | USD 69.52 |
| Open | USD 69.52 |
| Day Range | USD 68.39 – 70.8 |
| 52-Week Range | USD 23.13 – 97.97 |
| Volume | 29,627 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SLGL)
Nexqual's technical model rates SLGL "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:15 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.54 (neutral) |
| vs SMA50 | Below (USD 78.42) |
| MACD | -2.96 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | USD 5.3 | ▼ 1.67% |
| STRO | Sutro Biopharma, Inc. | USD 20.07 | ▼ 1.95% |
| URGN | UroGen Pharma Ltd. | USD 44.09 | ▼ 0.74% |
| MDWD | MediWound Ltd. | USD 13.29 | ▲ 1.76% |
| SYBX | Synlogic, Inc. | USD 1.17 | ▼ 4.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:15 UTC. This page is informational and not investment advice.